Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for InfuSystems Holdings, Inc. (INFU : AMEX)

• Company Description    InfuSystem is a rapidly growing healthcare services company that provides state-of-the-art electronic continuous ambulatory infusion pumps, supplies and support to oncology practices and clinics throughout the United States. More than 60% of oncologists across all 50 states turn to InfuSystem as their single, full-service source for cost-effective infusion pump management. Number of Employees: 407

• Price / Volume Information    Yesterday's Closing Price: $8.58 Daily Weekly Monthly 20 Day Moving Average: 169,749 shares Shares Outstanding: 20.54 (millions) Market Capitalization: $176.23 (millions) Beta: 1.23 52 Week High: $21.89 52 Week Low: $6.78 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 6.85% 16.61% 12 Week -22.21% -18.10% Year To Date -49.62% -41.27%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3851 West Hamlin Road - Rochester Hills,MI 48309 USA ph: 248-291-1210 fax: 800-455-4338 None http://www.infusystem.com

• General Corporate Information    Officers Richard DiIorio - Chief Executive Officer Scott Shuda - Chairman Carrie Lachance - President and Chief Operating Officer Barry Steele - Chief Financial Officer Paul Gendron - Director Peer Information InfuSystems Holdings, Inc. (BJCT) InfuSystems Holdings, Inc. (CADMQ) InfuSystems Holdings, Inc. (APNO) InfuSystems Holdings, Inc. (UPDC) InfuSystems Holdings, Inc. (IMTIQ) InfuSystems Holdings, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 45685K102 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/11/22 Share - Related Items Shares Outstanding: 20.54 Most Recent Split Date: (:1) Beta: 1.23 Market Capitalization: $176.23 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/11/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 429.00 PEG Ratio: - Price Ratios Price/Book: 3.83 Price/Cash Flow: 10.94 Price / Sales: 1.68 EPS Growth vs. Year Ago Period: -166.67% vs. Previous Quarter: -200.00% Sales Growth vs. Year Ago Period: 9.40% vs. Previous Quarter: 0.92% ROE 03/31/22 - 0.84 12/31/21 - 3.11 09/30/21 - 26.77 ROA 03/31/22 - 0.40 12/31/21 - 1.50 09/30/21 - 12.37 Current Ratio 03/31/22 - 1.67 12/31/21 - 1.71 09/30/21 - 1.51 Quick Ratio 03/31/22 - 1.39 12/31/21 - 1.41 09/30/21 - 1.25 Operating Margin 03/31/22 - 0.37 12/31/21 - 1.39 09/30/21 - 11.64 Net Margin 03/31/22 - 0.37 12/31/21 - 1.39 09/30/21 - 11.64 Pre-Tax Margin 03/31/22 - -0.05 12/31/21 - 1.23 09/30/21 - 0.94 Book Value 03/31/22 - 2.24 12/31/21 - 2.34 09/30/21 - 2.26 Inventory Turnover 03/31/22 - 11.47 12/31/21 - 11.56 09/30/21 - 11.92 Debt-to-Equity 03/31/22 - 0.76 12/31/21 - 0.68 09/30/21 - 0.66 Debt-to-Capital 03/31/22 - 43.03 12/31/21 - 40.42 09/30/21 - 39.68

Powered by Zacks Investment Research ©